Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Long-term results in elderly patients with differentiated thyroid carcinoma.

Vini L, Hyer SL, Marshall J, A'Hern R, Harmer C.

Cancer. 2003 Jun 1;97(11):2736-42.

2.

Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.

Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI.

Cancer. 2003 Mar 1;97(5):1186-94.

3.

Survival and prognosis in Hürthle cell carcinoma of the thyroid gland.

Bhattacharyya N.

Arch Otolaryngol Head Neck Surg. 2003 Feb;129(2):207-10.

PMID:
12578450
4.

Hürthle cell carcinoma: a 60-year experience.

Stojadinovic A, Hoos A, Ghossein RA, Urist MJ, Leung DH, Spiro RH, Shah JP, Brennan MF, Singh B, Shaha AR.

Ann Surg Oncol. 2002 Mar;9(2):197-203.

PMID:
11888879
5.

Cause of death in patients with well-differentiated thyroid carcinoma.

Beasley NJ, Walfish PG, Witterick I, Freeman JL.

Laryngoscope. 2001 Jun;111(6):989-91.

PMID:
11404609
6.

Hürthle cell carcinoma: a critical histopathologic appraisal.

Stojadinovic A, Ghossein RA, Hoos A, Urist MJ, Spiro RH, Shah JP, Brennan MF, Shaha AR, Singh B.

J Clin Oncol. 2001 May 15;19(10):2616-25.

PMID:
11352953
7.

Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid.

Udelsman R, Westra WH, Donovan PI, Sohn TA, Cameron JL.

Ann Surg. 2001 May;233(5):716-22.

8.

Combined tall cell carcinoma and Hürthle cell carcinoma (collision tumor) of the thyroid.

Baloch ZW, Mandel S, LiVolsi VA.

Arch Pathol Lab Med. 2001 Apr;125(4):541-3.

PMID:
11260633
9.

Hürthle cell carcinoma: A malignancy of low-grade potential.

Khafif A, Khafif RA, Attie JN.

Head Neck. 1999 Sep;21(6):506-11.

PMID:
10449665
10.

Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy.

Sanders LE, Silverman M.

Surgery. 1998 Dec;124(6):967-74.

PMID:
9854570
11.

The use of radioactive iodine in patients with papillary and follicular thyroid cancer.

Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID.

J Clin Endocrinol Metab. 1998 Dec;83(12):4195-203. Review. No abstract available.

PMID:
9851751
12.

Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia.

Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL.

J Clin Endocrinol Metab. 1998 Nov;83(11):4116-22.

PMID:
9814501
13.

Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident.

Miccoli P, Antonelli A, Spinelli C, Ferdeghini M, Fallahi P, Baschieri L.

Arch Surg. 1998 Jan;133(1):89-93.

PMID:
9438766
14.
15.
16.

Hürthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment.

McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J.

Surgery. 1996 Dec;120(6):1000-4; discussion 1004-5.

PMID:
8957486
17.

Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.

Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C.

J Nucl Med. 1996 Apr;37(4):598-605.

18.

Follicular thyroid cancer.

Grebe SK, Hay ID.

Endocrinol Metab Clin North Am. 1995 Dec;24(4):761-801. Review.

PMID:
8608779
19.

Pulmonary metastases in children and young adults with differentiated thyroid cancer.

Vassilopoulou-Sellin R, Klein MJ, Smith TH, Samaan NA, Frankenthaler RA, Goepfert H, Cangir A, Haynie TP.

Cancer. 1993 Feb 15;71(4):1348-52.

20.

Value of fine-needle aspiration in the diagnosis of Hürthle cell neoplasms.

McIvor NP, Freeman JL, Rosen I, Bedard YC.

Head Neck. 1993 Jul-Aug;15(4):335-41.

PMID:
8360056
Items per page

Supplemental Content

Write to the Help Desk